Impact of nesiritide on renal function and mortality in patients suffering from heart failure

Cardiovascular Drugs and Therapy

Volumn 23, Issue 3, 2009, Pages 221-233

  Dontas, Ioannis D ^a   Xanthos, Theodoros ^a   Dontas, Ismene ^a   Lelovas, Pavlos ^a   Papadimitriou, Lila ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Heart failure; Mortality; Nesiritide; Renal function

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; NESIRITIDE; PLACEBO;

ACUTE HEART FAILURE; ACUTE KIDNEY FAILURE; CLINICAL TRIAL; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG EFFICACY; DYSPNEA; HEART FAILURE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MORTALITY; NONHUMAN; OLIGURIA; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SIDE EFFECT; SURVIVAL; UREA NITROGEN BLOOD LEVEL;

BLOOD UREA NITROGEN; CREATININE; DYSPNEA; HEART FAILURE; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; RENAL INSUFFICIENCY; SURVIVAL ANALYSIS;

EID: 67649135884     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-009-6167-6     Document Type: Review

References (40)

1. GS Bleumink AM Knetsch MC Sturkenboom 2004 Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study Eur Heart J 25 1614 1619 (Pubitemid 39209281)
2. RM Mills TH LeJemtel DP Horton 1999 Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group J Am Coll Cardiol 34 155 162
3. WS Colucci U Elkayam DP Horton 2000 Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group N Engl J Med 343 246 253 (Pubitemid 30490392)
4. M Yoshimura H Yasue E Morita 1991 Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure Circulation 84 1581 1588
5. SJ Holmes EA Espiner AM Richards TG Yandle C Frampton 1993 Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man J Clin Endocrinol Metab 76 91 96
6. K van der Zander AJ Houben AA Kroon PW de Leeuw 1999 Effects of brain natriuretic peptide on forearm vasculature: comparison with atrial natriuretic peptide Cardiovasc Res 44 595 600 (Pubitemid 30012063)
7. JD Sackner-Bernstein HA Skopicki KD Aaronson 2005 Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure Circulation 111 1487 1491 (Pubitemid 40470642)
8. JD Sackner-Bernstein M Kowalski M Fox K Aaronson 2005 Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials JAMA 293 1900 1905 (Pubitemid 40548187)
9. PJ Hauptman MA Schnitzler J Swindle TE Burroughs 2006 Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure JAMA 296 1877 1884 (Pubitemid 44584000)
10. RM Witteles D Kao D Christopherson 2007 Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial J Am Coll Cardiol 50 1835 1840 (Pubitemid 350007964)
11. S Arora K Clarke V Srinivasan A Gradman 2007 Effect of nesiritide on renal function in patients admitted for decompensated heart failure QJM 100 699 706 (Pubitemid 350042430)
12. DJ Wang TC Dowling D Meadows 2004 Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine Circulation 110 1620 1625 (Pubitemid 39297985)
13. HH Chen TM Sundt DJ Cook DM Heublein JC Burnett Jr 2007 Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study Circulation 116 I134 I138
14. RM Mentzer Jr MC Oz RN Sladen 2007 NAPA Investigators. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA Trial J Am Coll Cardiol 49 716 726 (Pubitemid 46205038)
15. AH Miller S Nazeer P Pepe B Estes A Gorman CW Yancy 2008 Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment Ann Emerg Med 51 571 578
16. TE Owan HH Chen RP Frantz 2008 The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction J Card Fail 14 267 275 (Pubitemid 351636237)
17. J Butler C Emerman WF Peacock VS Mathur JB Young 2004 VMAC study investigators. The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure Nephrol Dial Transplant 19 391 399 (Pubitemid 38195989)
18. LS Marcus D Hart M Packer 1996 Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial Circulation 94 3184 3189 (Pubitemid 26427485)
19. J Iglesias D Hom M Antoniotti S Ayoub JS Levine 2006 Predictors of worsening renal function in adult patients with congestive heart failure receiving recombinant human B-type brain natriuretic peptide (nesiritide) Nephrol Dial Transplant 21 3458 3465 (Pubitemid 44817095)
20. EJ Velazquez GS Francis PW Armstrong 2004 VALIANT registry. An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry Eur Heart J 25 1911 1919 (Pubitemid 39452608)
21. SP D'Souza DM Yellon C Martin 2003 B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening Am J Physiol Heart Circ Physiol 284 H1592 H1600
22. B Ren Y Shen H Shao J Qian H Wu H Jing 2007 Brain natriuretic peptide limits myocardial infarct size dependent of nitric oxide synthase in rats Clin Chim Acta 377 83 87 (Pubitemid 44908233)
23. RJ Hillock CM Frampton TG Yandle RW Troughton JG Lainchbury AM Richards 2008 B-type natriuretic peptide infusions in acute myocardial infarction Heart 94 617 622 (Pubitemid 351580137)
24. S Kurien KT Warfield CM Wood WL Miller 2006 Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide Am J Cardiol 98 1627 1630 (Pubitemid 44827974)
25. CW Yancy MT Saltzberg RL Berkowitz 2004 Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial) Am J Cardiol 94 595 601 (Pubitemid 39165837)
26. CW Yancy A Singh 2006 Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] trial) Am J Cardiol 98 226 229 (Pubitemid 43975501)
27. JG Cleland AP Coletta AL Clark 2007 Clinical trials update from the American College of Cardiology 2007: ALPHA, EVEREST, FUSION II, VALIDD, PARR-2, REMODEL, SPICE, COURAGE, COACH, REMADHE, pro-BNP for the evaluation of dyspnoea and THIS-diet Eur J Heart Fail 9 740 745 (Pubitemid 46702830)
28. WL Miller S Kurien KT Warfield CM Wood AS Jaffe 2008 Lack of association between worsening renal function and mortality in heart failure patients treated with nesiritide Int J Cardiol 126 234 239 (Pubitemid 351602105)
29. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF) 2002 Intravenous nesiritide vs nitroglycerin for treatment of dec.ompensated congestive heart failure: a randomized controlled trial JAMA 287 1531 1540
30. WF Peacock CL Emerman MA Silver 2005 Nesiritide added to standard care favorably reduces systolic blood pressure compared with standard care alone in patients with acute decompensated heart failure Am J Emerg Med 23 327 331 (Pubitemid 40732268)
31. RR Arora PK Venkatesh J Molnar 2006 Short and long-term mortality with nesiritide Am Heart J 152 1084 1090 (Pubitemid 44854791)
32. AJ Burger DP Horton T LeJemtel 2002 Prospective Randomized Evaluation of Cardiac Ectopy with Dobutamine or Natrecor Therapy Effect. of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study Am Heart J 144 1102 1108
33. RJ Carroll ZD Mulla LD Hauck A Westbrook 2007 Outcomes of patients hospitalized for acute decompensated heart failure: does nesiritide make a difference? BMC Cardiovasc Disord 7 37
34. A Sakr P Hahn T Donohue A Ghantous 2008 Nesiritide in the initial management of acute decompensated congestive heart failure Conn Med 72 517 523
35. J Iglesias L DePalma D Hom M Antoniotti S Ayoub J Levine 2008 Predictors of mortality in adult patients with congestive heart failure receiving nesiritide-Retrospective analysis showing a potential adverse interaction between neseritide and acute renal dysfunction Nephrol Dial Transplant 23 144 153 (Pubitemid 351767377)
36. RJ DiDomenico HY Park MR Southworth 2004 Guidelines for acute decompensated heart failure treatment Ann Pharmacother 38 649 660 (Pubitemid 38352231)
37. MS Nieminen M Böhm MR Cowie 2005 ESC Committe for Practice Guideline (CPG). Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology Eur Heart J 26 384 416 (Pubitemid 40283098)
38. AJ Burger U Elkayam MT Neibaur 2001 Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy Am J Cardiol 88 35 39 (Pubitemid 32553889)
39. CW Yancy H Krum BM Massie 2007 FUSION II Investigators. The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: study rationale and design Am Heart J 153 478 484 (Pubitemid 46442809)
40. EF Lewis PA Johnson W Johnson C Collins L Griffin LW Stevenson 2001 Preferences for quality of life or survival expressed by patients with heart failure J Heart Lung Transplant 20 1016 1024 (Pubitemid 32824149)